세계의 세포치료 시장 분석과 예측(-2033년) : 유형, 제품, 서비스, 기술, 용도, 최종사용자, 프로세스, 방법, 스테이지

The cell therapy market is anticipated to expand from $7.8 billion in 2023 to $30.1 billion by 2033, driven by a CAGR of 14.8%, reflecting robust growth.

The cell therapy market encompasses the development, commercialization, and application of treatments that use living cells to repair, replace, or regenerate damaged tissues and organs. This rapidly evolving sector includes autologous and allogeneic therapies, stem cell treatments, and gene-editing technologies, targeting a range of conditions from cancer to degenerative diseases, driven by advancements in biotechnology and increasing investment in regenerative medicine.

The market is witnessing growth, driven by advancements in regenerative medicine and increasing prevalence of chronic diseases. Among the various segments, stem cell therapy emerges as the top-performing sub-segment, owing to its potential to treat a wide array of conditions and its ongoing clinical trials. CAR-T cell therapy follows as the second-highest performing sub-segment, with its promising results in cancer treatment and recent FDA approvals enhancing its market appeal. Geographically, North America leads the market, attributed to its strong healthcare infrastructure and substantial investment in research and development. Europe holds the position of the second-highest performing region, supported by favorable regulatory frameworks and increasing adoption of advanced therapies. Within these regions, the United States and Germany are the top-performing countries, respectively, due to their cutting-edge research facilities and supportive government policies. The cell therapy market is poised for further expansion as innovations and strategic collaborations continue to unfold.

In 2023, the Cell Therapy Market demonstrated robust dynamics, with an estimated market volume reaching 120 million procedures globally, projected to expand to 250 million by 2033. The allogeneic segment commands the largest market share at 55%, driven by its scalability and reduced manufacturing costs, while the autologous segment holds a 45% share, favored for its personalized treatment approach. The oncology sector remains the predominant application area, accounting for 60% of the market share, followed by cardiovascular and musculoskeletal disorders at 20% and 15%, respectively. Key players such as Novartis, Gilead Sciences, and Bluebird Bio are pivotal, with Novartis leading in CAR-T cell therapies, influencing market trends and competitive dynamics.

The regulatory landscape is characterized by stringent guidelines from entities like the FDA and EMA, which significantly impact market operations, particularly in terms of approval timelines and compliance costs. The integration of AI and machine learning in therapy development is anticipated to enhance efficacy and reduce time-to-market. Despite promising growth, challenges such as high treatment costs and complex manufacturing processes remain. Nonetheless, emerging markets and government funding initiatives offer lucrative opportunities for expansion, underscoring a positive outlook for the Cell Therapy Market.

The cell therapy market exhibits a dynamic regional landscape, with North America commanding a substantial share. This dominance is attributed to the presence of a robust healthcare infrastructure, significant investment in research and development, and a favorable regulatory environment. The United States, in particular, stands at the forefront, driven by its pioneering role in biotechnological advancements and a strong network of academic and research institutions. Furthermore, the region's proactive stance in adopting cutting-edge medical technologies fuels its leadership in the cell therapy domain.

Europe follows closely, with countries like Germany, the United Kingdom, and France spearheading the market. The region benefits from a well-established healthcare system and a strong emphasis on innovation. European governments' supportive policies and funding for regenerative medicine research further enhance the market's growth prospects. Additionally, the collaboration between academia, industry, and regulatory bodies in Europe fosters a conducive environment for the development and commercialization of cell therapies.

The Asia Pacific region is emerging as a significant player in the cell therapy market, propelled by rapid economic growth and increasing healthcare expenditure. Countries such as China, Japan, and South Korea are investing heavily in biotechnology and life sciences, aiming to capitalize on the therapeutic potential of cell-based treatments. The region's large patient pool and growing prevalence of chronic diseases present lucrative opportunities for market expansion. Moreover, the regulatory landscape in Asia Pacific is gradually evolving, with efforts to streamline approval processes and encourage innovation in the field of cell therapy.

Latin America and the Middle East and Africa, while currently representing smaller shares of the global market, are witnessing a gradual uptick in cell therapy adoption. In Latin America, Brazil and Mexico are at the forefront, driven by increasing awareness of advanced therapeutic options and government initiatives to boost healthcare infrastructure. Similarly, in the Middle East and Africa, countries such as the United Arab Emirates and South Africa are making strides in improving healthcare access and investing in medical research, thereby paving the way for future growth in the cell therapy market.

Key Companies

Bluebird Bio, Sangamo Therapeutics, Adaptimmune Therapeutics, Atara Biotherapeutics, Cellectis, Fate Therapeutics, Gamida Cell, Kiadis Pharma, Mesoblast, Orchard Therapeutics, Poseida Therapeutics, Precision Bio Sciences, Regenxbio, Rubius Therapeutics, Sorrento Therapeutics, TCR2 Therapeutics, Unum Therapeutics, Vericel, Ziopharm Oncology, Allogene Therapeutics

Sources

U.S. Food and Drug Administration - Center for Biologics Evaluation and Research, European Medicines Agency, National Institutes of Health - National Center for Advancing Translational Sciences, World Health Organization - Global Observatory on Health R&D, International Society for Cellular Therapy, International Society for Stem Cell Research, Alliance for Regenerative Medicine, National Institute for Health and Care Excellence (NICE), Biotechnology Innovation Organization, Cell & Gene Therapy Catapult (UK), Japan Agency for Medical Research and Development, Centre for Commercialization of Regenerative Medicine (Canada), International Society for Cell & Gene Therapy, U.S. National Institute of Standards and Technology, European Federation of Pharmaceutical Industries and Associations, U.S. Department of Health and Human Services, California Institute for Regenerative Medicine, Harvard Stem Cell Institute, International Conference on Cell and Stem Cell Research, World Stem Cell Summit

Research Scope

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Cell Therapy Market Overview

• 1.1 Objectives of the Study
• 1.2 Cell Therapy Market Definition and Scope of the Report
• 1.3 Report Limitations
• 1.4 Years & Currency Considered in the Study
• 1.5 Research Methodologies
  • 1.5.1 Secondary Research
  • 1.5.2 Primary Research
  • 1.5.3 Market Size Estimation: Top-Down Approach
  • 1.5.4 Market Size Estimation: Bottom-Up Approach
  • 1.5.5 Data Triangulation and Validation

2: Executive Summary

• 2.1 Summary
• 2.2 Key Opinion Leaders
• 2.3 Key Highlights of the Market, by Type
• 2.4 Key Highlights of the Market, by Product
• 2.5 Key Highlights of the Market, by Services
• 2.6 Key Highlights of the Market, by Technology
• 2.7 Key Highlights of the Market, by Application
• 2.8 Key Highlights of the Market, by End User
• 2.9 Key Highlights of the Market, by Process
• 2.10 Key Highlights of the Market, by Mode
• 2.11 Key Highlights of the Market, by Stage
• 2.12 Key Highlights of the Market, by North America
• 2.13 Key Highlights of the Market, by Europe
• 2.14 Key Highlights of the Market, by Asia-Pacific
• 2.15 Key Highlights of the Market, by Latin America
• 2.16 Key Highlights of the Market, by Middle East
• 2.17 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

• 3.1 Market Attractiveness Analysis, by Region
• 3.2 Market Attractiveness Analysis, by Type
• 3.3 Market Attractiveness Analysis, by Product
• 3.4 Market Attractiveness Analysis, by Services
• 3.5 Market Attractiveness Analysis, by Technology
• 3.6 Market Attractiveness Analysis, by Application
• 3.7 Market Attractiveness Analysis, by End User
• 3.8 Market Attractiveness Analysis, by Process
• 3.9 Market Attractiveness Analysis, by Mode
• 3.10 Market Attractiveness Analysis, by Stage
• 3.11 Market Attractiveness Analysis, by North America
• 3.12 Market Attractiveness Analysis, by Europe
• 3.13 Market Attractiveness Analysis, by Asia-Pacific
• 3.14 Market Attractiveness Analysis, by Latin America
• 3.15 Market Attractiveness Analysis, by Middle East
• 3.16 Market Attractiveness Analysis, by Africa

4: Cell Therapy Market Outlook

• 4.1 Cell Therapy Market Segmentation
• 4.2 Market Dynamics
  • 4.2.1 Market Drivers
  • 4.2.2 Market Trends
  • 4.2.3 Market Restraints
  • 4.2.4 Market Opportunities
• 4.3 Porters Five Forces Analysis
  • 4.3.1 Threat of New Entrants
  • 4.3.2 Threat of Substitutes
  • 4.3.3 Bargaining Power of Buyers
  • 4.3.4 Bargaining Power of Supplier
  • 4.3.5 Competitive Rivalry
• 4.4 PESTLE Analysis
• 4.5 Value Chain Analysis
• 4.6 4Ps Model
• 4.7 ANSOFF Matrix

5: Cell Therapy Market Strategy

• 5.1 Parent Market Analysis
• 5.2 Supply-Demand Analysis
• 5.3 Consumer Buying Interest
• 5.4 Case Study Analysis
• 5.5 Pricing Analysis
• 5.6 Regulatory Landscape
• 5.7 Supply Chain Analysis
• 5.8 Competition Product Analysis
• 5.9 Recent Developments

6: Cell Therapy Market Size

• 6.1 Cell Therapy Market Size, by Value
• 6.2 Cell Therapy Market Size, by Volume

7: Cell Therapy Market, by Type

• 7.1 Market Overview
• 7.2 Autologous
  • 7.2.1 Key Market Trends & Opportunity Analysis
  • 7.2.2 Market Size and Forecast, by Region
• 7.3 Allogeneic
  • 7.3.1 Key Market Trends & Opportunity Analysis
  • 7.3.2 Market Size and Forecast, by Region
• 7.4 Xenogeneic
  • 7.4.1 Key Market Trends & Opportunity Analysis
  • 7.4.2 Market Size and Forecast, by Region
• 7.5 Syngeneic
  • 7.5.1 Key Market Trends & Opportunity Analysis
  • 7.5.2 Market Size and Forecast, by Region
• 7.6 Others
  • 7.6.1 Key Market Trends & Opportunity Analysis
  • 7.6.2 Market Size and Forecast, by Region

8: Cell Therapy Market, by Product

• 8.1 Market Overview
• 8.2 Stem Cell Therapy
  • 8.2.1 Key Market Trends & Opportunity Analysis
  • 8.2.2 Market Size and Forecast, by Region
• 8.3 Non-Stem Cell Therapy
  • 8.3.1 Key Market Trends & Opportunity Analysis
  • 8.3.2 Market Size and Forecast, by Region
• 8.4 Immune Cell Therapy
  • 8.4.1 Key Market Trends & Opportunity Analysis
  • 8.4.2 Market Size and Forecast, by Region
• 8.5 Gene-Modified Cell Therapy
  • 8.5.1 Key Market Trends & Opportunity Analysis
  • 8.5.2 Market Size and Forecast, by Region
• 8.6 Others
  • 8.6.1 Key Market Trends & Opportunity Analysis
  • 8.6.2 Market Size and Forecast, by Region

9: Cell Therapy Market, by Services

• 9.1 Market Overview
• 9.2 Manufacturing
  • 9.2.1 Key Market Trends & Opportunity Analysis
  • 9.2.2 Market Size and Forecast, by Region
• 9.3 Storage
  • 9.3.1 Key Market Trends & Opportunity Analysis
  • 9.3.2 Market Size and Forecast, by Region
• 9.4 Distribution
  • 9.4.1 Key Market Trends & Opportunity Analysis
  • 9.4.2 Market Size and Forecast, by Region
• 9.5 Consulting
  • 9.5.1 Key Market Trends & Opportunity Analysis
  • 9.5.2 Market Size and Forecast, by Region
• 9.6 Quality Assurance
  • 9.6.1 Key Market Trends & Opportunity Analysis
  • 9.6.2 Market Size and Forecast, by Region
• 9.7 Regulatory Compliance
  • 9.7.1 Key Market Trends & Opportunity Analysis
  • 9.7.2 Market Size and Forecast, by Region
• 9.8 Others
  • 9.8.1 Key Market Trends & Opportunity Analysis
  • 9.8.2 Market Size and Forecast, by Region

10: Cell Therapy Market, by Technology

• 10.1 Market Overview
• 10.2 CRISPR
  • 10.2.1 Key Market Trends & Opportunity Analysis
  • 10.2.2 Market Size and Forecast, by Region
• 10.3 TALEN
  • 10.3.1 Key Market Trends & Opportunity Analysis
  • 10.3.2 Market Size and Forecast, by Region
• 10.4 ZFN
  • 10.4.1 Key Market Trends & Opportunity Analysis
  • 10.4.2 Market Size and Forecast, by Region
• 10.5 Sleeping Beauty Transposon
  • 10.5.1 Key Market Trends & Opportunity Analysis
  • 10.5.2 Market Size and Forecast, by Region
• 10.6 Lentiviral
  • 10.6.1 Key Market Trends & Opportunity Analysis
  • 10.6.2 Market Size and Forecast, by Region
• 10.7 Adenoviral
  • 10.7.1 Key Market Trends & Opportunity Analysis
  • 10.7.2 Market Size and Forecast, by Region
• 10.8 Others
  • 10.8.1 Key Market Trends & Opportunity Analysis
  • 10.8.2 Market Size and Forecast, by Region

11: Cell Therapy Market, by Application

• 11.1 Market Overview
• 11.2 Oncology
  • 11.2.1 Key Market Trends & Opportunity Analysis
  • 11.2.2 Market Size and Forecast, by Region
• 11.3 Cardiovascular
  • 11.3.1 Key Market Trends & Opportunity Analysis
  • 11.3.2 Market Size and Forecast, by Region
• 11.4 Neurology
  • 11.4.1 Key Market Trends & Opportunity Analysis
  • 11.4.2 Market Size and Forecast, by Region
• 11.5 Orthopedic
  • 11.5.1 Key Market Trends & Opportunity Analysis
  • 11.5.2 Market Size and Forecast, by Region
• 11.6 Dermatology
  • 11.6.1 Key Market Trends & Opportunity Analysis
  • 11.6.2 Market Size and Forecast, by Region
• 11.7 Ophthalmology
  • 11.7.1 Key Market Trends & Opportunity Analysis
  • 11.7.2 Market Size and Forecast, by Region
• 11.8 Hematology
  • 11.8.1 Key Market Trends & Opportunity Analysis
  • 11.8.2 Market Size and Forecast, by Region
• 11.9 Others
  • 11.9.1 Key Market Trends & Opportunity Analysis
  • 11.9.2 Market Size and Forecast, by Region

12: Cell Therapy Market, by End User

• 12.1 Market Overview
• 12.2 Hospitals
  • 12.2.1 Key Market Trends & Opportunity Analysis
  • 12.2.2 Market Size and Forecast, by Region
• 12.3 Clinics
  • 12.3.1 Key Market Trends & Opportunity Analysis
  • 12.3.2 Market Size and Forecast, by Region
• 12.4 Research Institutes
  • 12.4.1 Key Market Trends & Opportunity Analysis
  • 12.4.2 Market Size and Forecast, by Region
• 12.5 Biopharmaceutical Companies
  • 12.5.1 Key Market Trends & Opportunity Analysis
  • 12.5.2 Market Size and Forecast, by Region
• 12.6 Academic Institutions
  • 12.6.1 Key Market Trends & Opportunity Analysis
  • 12.6.2 Market Size and Forecast, by Region
• 12.7 Others
  • 12.7.1 Key Market Trends & Opportunity Analysis
  • 12.7.2 Market Size and Forecast, by Region

13: Cell Therapy Market, by Process

• 13.1 Market Overview
• 13.2 Cell Expansion
  • 13.2.1 Key Market Trends & Opportunity Analysis
  • 13.2.2 Market Size and Forecast, by Region
• 13.3 Cell Preservation
  • 13.3.1 Key Market Trends & Opportunity Analysis
  • 13.3.2 Market Size and Forecast, by Region
• 13.4 Cell Separation
  • 13.4.1 Key Market Trends & Opportunity Analysis
  • 13.4.2 Market Size and Forecast, by Region
• 13.5 Cell Culture
  • 13.5.1 Key Market Trends & Opportunity Analysis
  • 13.5.2 Market Size and Forecast, by Region
• 13.6 Cell Engineering
  • 13.6.1 Key Market Trends & Opportunity Analysis
  • 13.6.2 Market Size and Forecast, by Region
• 13.7 Others
  • 13.7.1 Key Market Trends & Opportunity Analysis
  • 13.7.2 Market Size and Forecast, by Region

14: Cell Therapy Market, by Mode

• 14.1 Market Overview
• 14.2 In Vivo
  • 14.2.1 Key Market Trends & Opportunity Analysis
  • 14.2.2 Market Size and Forecast, by Region
• 14.3 Ex Vivo
  • 14.3.1 Key Market Trends & Opportunity Analysis
  • 14.3.2 Market Size and Forecast, by Region
• 14.4 Others
  • 14.4.1 Key Market Trends & Opportunity Analysis
  • 14.4.2 Market Size and Forecast, by Region

15: Cell Therapy Market, by Stage

• 15.1 Market Overview
• 15.2 Preclinical
  • 15.2.1 Key Market Trends & Opportunity Analysis
  • 15.2.2 Market Size and Forecast, by Region
• 15.3 Clinical Trials
  • 15.3.1 Key Market Trends & Opportunity Analysis
  • 15.3.2 Market Size and Forecast, by Region
• 15.4 Commercialization
  • 15.4.1 Key Market Trends & Opportunity Analysis
  • 15.4.2 Market Size and Forecast, by Region
• 15.5 Others
  • 15.5.1 Key Market Trends & Opportunity Analysis
  • 15.5.2 Market Size and Forecast, by Region

16: Cell Therapy Market, by Region

• 16.1 Overview
• 16.2 North America
  • 16.2.1 Key Market Trends and Opportunities
  • 16.2.2 North America Market Size and Forecast, by Type
  • 16.2.3 North America Market Size and Forecast, by Product
  • 16.2.4 North America Market Size and Forecast, by Services
  • 16.2.5 North America Market Size and Forecast, by Technology
  • 16.2.6 North America Market Size and Forecast, by Application
  • 16.2.7 North America Market Size and Forecast, by End User
  • 16.2.8 North America Market Size and Forecast, by Process
  • 16.2.9 North America Market Size and Forecast, by Mode
  • 16.2.10 North America Market Size and Forecast, by Stage
  • 16.2.11 North America Market Size and Forecast, by Country
  • 16.2.12 United States
    • 16.2.9.1 United States Market Size and Forecast, by Type
    • 16.2.9.2 United States Market Size and Forecast, by Product
    • 16.2.9.3 United States Market Size and Forecast, by Services
    • 16.2.9.4 United States Market Size and Forecast, by Technology
    • 16.2.9.5 United States Market Size and Forecast, by Application
    • 16.2.9.6 United States Market Size and Forecast, by End User
    • 16.2.9.7 United States Market Size and Forecast, by Process
    • 16.2.9.8 United States Market Size and Forecast, by Mode
    • 16.2.9.9 United States Market Size and Forecast, by Stage
    • 16.2.9.10 Local Competition Analysis
    • 16.2.9.11 Local Market Analysis
  • 16.2.1 Canada
    • 16.2.10.1 Canada Market Size and Forecast, by Type
    • 16.2.10.2 Canada Market Size and Forecast, by Product
    • 16.2.10.3 Canada Market Size and Forecast, by Services
    • 16.2.10.4 Canada Market Size and Forecast, by Technology
    • 16.2.10.5 Canada Market Size and Forecast, by Application
    • 16.2.10.6 Canada Market Size and Forecast, by End User
    • 16.2.10.7 Canada Market Size and Forecast, by Process
    • 16.2.10.8 Canada Market Size and Forecast, by Mode
    • 16.2.10.9 Canada Market Size and Forecast, by Stage
    • 16.2.10.10 Local Competition Analysis
    • 16.2.10.11 Local Market Analysis
• 16.1 Europe
  • 16.3.1 Key Market Trends and Opportunities
  • 16.3.2 Europe Market Size and Forecast, by Type
  • 16.3.3 Europe Market Size and Forecast, by Product
  • 16.3.4 Europe Market Size and Forecast, by Services
  • 16.3.5 Europe Market Size and Forecast, by Technology
  • 16.3.6 Europe Market Size and Forecast, by Application
  • 16.3.7 Europe Market Size and Forecast, by End User
  • 16.3.8 Europe Market Size and Forecast, by Process
  • 16.3.9 Europe Market Size and Forecast, by Mode
  • 16.3.10 Europe Market Size and Forecast, by Stage
  • 16.3.11 Europe Market Size and Forecast, by Country
  • 16.3.12 United Kingdom
    • 16.3.9.1 United Kingdom Market Size and Forecast, by Type
    • 16.3.9.2 United Kingdom Market Size and Forecast, by Product
    • 16.3.9.3 United Kingdom Market Size and Forecast, by Services
    • 16.3.9.4 United Kingdom Market Size and Forecast, by Technology
    • 16.3.9.5 United Kingdom Market Size and Forecast, by Application
    • 16.3.9.6 United Kingdom Market Size and Forecast, by End User
    • 16.3.9.7 United Kingdom Market Size and Forecast, by Process
    • 16.3.9.8 United Kingdom Market Size and Forecast, by Mode
    • 16.3.9.9 United Kingdom Market Size and Forecast, by Stage
    • 16.3.9.10 Local Competition Analysis
    • 16.3.9.11 Local Market Analysis
  • 16.3.1 Germany
    • 16.3.10.1 Germany Market Size and Forecast, by Type
    • 16.3.10.2 Germany Market Size and Forecast, by Product
    • 16.3.10.3 Germany Market Size and Forecast, by Services
    • 16.3.10.4 Germany Market Size and Forecast, by Technology
    • 16.3.10.5 Germany Market Size and Forecast, by Application
    • 16.3.10.6 Germany Market Size and Forecast, by End User
    • 16.3.10.7 Germany Market Size and Forecast, by Process
    • 16.3.10.8 Germany Market Size and Forecast, by Mode
    • 16.3.10.9 Germany Market Size and Forecast, by Stage
    • 16.3.10.10 Local Competition Analysis
    • 16.3.10.11 Local Market Analysis
  • 16.3.1 France
    • 16.3.11.1 France Market Size and Forecast, by Type
    • 16.3.11.2 France Market Size and Forecast, by Product
    • 16.3.11.3 France Market Size and Forecast, by Services
    • 16.3.11.4 France Market Size and Forecast, by Technology
    • 16.3.11.5 France Market Size and Forecast, by Application
    • 16.3.11.6 France Market Size and Forecast, by End User
    • 16.3.11.7 France Market Size and Forecast, by Process
    • 16.3.11.8 France Market Size and Forecast, by Mode
    • 16.3.11.9 France Market Size and Forecast, by Stage
    • 16.3.11.10 Local Competition Analysis
    • 16.3.11.11 Local Market Analysis
  • 16.3.1 Spain
    • 16.3.12.1 Spain Market Size and Forecast, by Type
    • 16.3.12.2 Spain Market Size and Forecast, by Product
    • 16.3.12.3 Spain Market Size and Forecast, by Services
    • 16.3.12.4 Spain Market Size and Forecast, by Technology
    • 16.3.12.5 Spain Market Size and Forecast, by Application
    • 16.3.12.6 Spain Market Size and Forecast, by End User
    • 16.3.12.7 Spain Market Size and Forecast, by Process
    • 16.3.12.8 Spain Market Size and Forecast, by Mode
    • 16.3.12.9 Spain Market Size and Forecast, by Stage
    • 16.3.12.10 Local Competition Analysis
    • 16.3.12.11 Local Market Analysis
  • 16.3.1 Italy
    • 16.3.13.1 Italy Market Size and Forecast, by Type
    • 16.3.13.2 Italy Market Size and Forecast, by Product
    • 16.3.13.3 Italy Market Size and Forecast, by Services
    • 16.3.13.4 Italy Market Size and Forecast, by Technology
    • 16.3.13.5 Italy Market Size and Forecast, by Application
    • 16.3.13.6 Italy Market Size and Forecast, by End User
    • 16.3.13.7 Italy Market Size and Forecast, by Process
    • 16.3.13.8 Italy Market Size and Forecast, by Mode
    • 16.3.13.9 Italy Market Size and Forecast, by Stage
    • 16.3.13.10 Local Competition Analysis
    • 16.3.13.11 Local Market Analysis
  • 16.3.1 Netherlands
    • 16.3.14.1 Netherlands Market Size and Forecast, by Type
    • 16.3.14.2 Netherlands Market Size and Forecast, by Product
    • 16.3.14.3 Netherlands Market Size and Forecast, by Services
    • 16.3.14.4 Netherlands Market Size and Forecast, by Technology
    • 16.3.14.5 Netherlands Market Size and Forecast, by Application
    • 16.3.14.6 Netherlands Market Size and Forecast, by End User
    • 16.3.14.7 Netherlands Market Size and Forecast, by Process
    • 16.3.14.8 Netherlands Market Size and Forecast, by Mode
    • 16.3.14.9 Netherlands Market Size and Forecast, by Stage
    • 16.3.14.10 Local Competition Analysis
    • 16.3.14.11 Local Market Analysis
  • 16.3.1 Sweden
    • 16.3.15.1 Sweden Market Size and Forecast, by Type
    • 16.3.15.2 Sweden Market Size and Forecast, by Product
    • 16.3.15.3 Sweden Market Size and Forecast, by Services
    • 16.3.15.4 Sweden Market Size and Forecast, by Technology
    • 16.3.15.5 Sweden Market Size and Forecast, by Application
    • 16.3.15.6 Sweden Market Size and Forecast, by End User
    • 16.3.15.7 Sweden Market Size and Forecast, by Process
    • 16.3.15.8 Sweden Market Size and Forecast, by Mode
    • 16.3.15.9 Sweden Market Size and Forecast, by Stage
    • 16.3.15.10 Local Competition Analysis
    • 16.3.15.11 Local Market Analysis
  • 16.3.1 Switzerland
    • 16.3.16.1 Switzerland Market Size and Forecast, by Type
    • 16.3.16.2 Switzerland Market Size and Forecast, by Product
    • 16.3.16.3 Switzerland Market Size and Forecast, by Services
    • 16.3.16.4 Switzerland Market Size and Forecast, by Technology
    • 16.3.16.5 Switzerland Market Size and Forecast, by Application
    • 16.3.16.6 Switzerland Market Size and Forecast, by End User
    • 16.3.16.7 Switzerland Market Size and Forecast, by Process
    • 16.3.16.8 Switzerland Market Size and Forecast, by Mode
    • 16.3.16.9 Switzerland Market Size and Forecast, by Stage
    • 16.3.16.10 Local Competition Analysis
    • 16.3.16.11 Local Market Analysis
  • 16.3.1 Denmark
    • 16.3.17.1 Denmark Market Size and Forecast, by Type
    • 16.3.17.2 Denmark Market Size and Forecast, by Product
    • 16.3.17.3 Denmark Market Size and Forecast, by Services
    • 16.3.17.4 Denmark Market Size and Forecast, by Technology
    • 16.3.17.5 Denmark Market Size and Forecast, by Application
    • 16.3.17.6 Denmark Market Size and Forecast, by End User
    • 16.3.17.7 Denmark Market Size and Forecast, by Process
    • 16.3.17.8 Denmark Market Size and Forecast, by Mode
    • 16.3.17.9 Denmark Market Size and Forecast, by Stage
    • 16.3.17.10 Local Competition Analysis
    • 16.3.17.11 Local Market Analysis
  • 16.3.1 Finland
    • 16.3.18.1 Finland Market Size and Forecast, by Type
    • 16.3.18.2 Finland Market Size and Forecast, by Product
    • 16.3.18.3 Finland Market Size and Forecast, by Services
    • 16.3.18.4 Finland Market Size and Forecast, by Technology
    • 16.3.18.5 Finland Market Size and Forecast, by Application
    • 16.3.18.6 Finland Market Size and Forecast, by End User
    • 16.3.18.7 Finland Market Size and Forecast, by Process
    • 16.3.18.8 Finland Market Size and Forecast, by Mode
    • 16.3.18.9 Finland Market Size and Forecast, by Stage
    • 16.3.18.10 Local Competition Analysis
    • 16.3.18.11 Local Market Analysis
  • 16.3.1 Russia
    • 16.3.19.1 Russia Market Size and Forecast, by Type
    • 16.3.19.2 Russia Market Size and Forecast, by Product
    • 16.3.19.3 Russia Market Size and Forecast, by Services
    • 16.3.19.4 Russia Market Size and Forecast, by Technology
    • 16.3.19.5 Russia Market Size and Forecast, by Application
    • 16.3.19.6 Russia Market Size and Forecast, by End User
    • 16.3.19.7 Russia Market Size and Forecast, by Process
    • 16.3.19.8 Russia Market Size and Forecast, by Mode
    • 16.3.19.9 Russia Market Size and Forecast, by Stage
    • 16.3.19.10 Local Competition Analysis
    • 16.3.19.11 Local Market Analysis
  • 16.3.1 Rest of Europe
    • 16.3.20.1 Rest of Europe Market Size and Forecast, by Type
    • 16.3.20.2 Rest of Europe Market Size and Forecast, by Product
    • 16.3.20.3 Rest of Europe Market Size and Forecast, by Services
    • 16.3.20.4 Rest of Europe Market Size and Forecast, by Technology
    • 16.3.20.5 Rest of Europe Market Size and Forecast, by Application
    • 16.3.20.6 Rest of Europe Market Size and Forecast, by End User
    • 16.3.20.7 Rest of Europe Market Size and Forecast, by Process
    • 16.3.20.8 Rest of Europe Market Size and Forecast, by Mode
    • 16.3.20.9 Rest of Europe Market Size and Forecast, by Stage
    • 16.3.20.10 Local Competition Analysis
    • 16.3.20.11 Local Market Analysis
• 16.1 Asia-Pacific
  • 16.4.1 Key Market Trends and Opportunities
  • 16.4.2 Asia-Pacific Market Size and Forecast, by Type
  • 16.4.3 Asia-Pacific Market Size and Forecast, by Product
  • 16.4.4 Asia-Pacific Market Size and Forecast, by Services
  • 16.4.5 Asia-Pacific Market Size and Forecast, by Technology
  • 16.4.6 Asia-Pacific Market Size and Forecast, by Application
  • 16.4.7 Asia-Pacific Market Size and Forecast, by End User
  • 16.4.8 Asia-Pacific Market Size and Forecast, by Process
  • 16.4.9 Asia-Pacific Market Size and Forecast, by Mode
  • 16.4.10 Asia-Pacific Market Size and Forecast, by Stage
  • 16.4.11 Asia-Pacific Market Size and Forecast, by Country
  • 16.4.12 China
    • 16.4.9.1 China Market Size and Forecast, by Type
    • 16.4.9.2 China Market Size and Forecast, by Product
    • 16.4.9.3 China Market Size and Forecast, by Services
    • 16.4.9.4 China Market Size and Forecast, by Technology
    • 16.4.9.5 China Market Size and Forecast, by Application
    • 16.4.9.6 China Market Size and Forecast, by End User
    • 16.4.9.7 China Market Size and Forecast, by Process
    • 16.4.9.8 China Market Size and Forecast, by Mode
    • 16.4.9.9 China Market Size and Forecast, by Stage
    • 16.4.9.10 Local Competition Analysis
    • 16.4.9.11 Local Market Analysis
  • 16.4.1 India
    • 16.4.10.1 India Market Size and Forecast, by Type
    • 16.4.10.2 India Market Size and Forecast, by Product
    • 16.4.10.3 India Market Size and Forecast, by Services
    • 16.4.10.4 India Market Size and Forecast, by Technology
    • 16.4.10.5 India Market Size and Forecast, by Application
    • 16.4.10.6 India Market Size and Forecast, by End User
    • 16.4.10.7 India Market Size and Forecast, by Process
    • 16.4.10.8 India Market Size and Forecast, by Mode
    • 16.4.10.9 India Market Size and Forecast, by Stage
    • 16.4.10.10 Local Competition Analysis
    • 16.4.10.11 Local Market Analysis
  • 16.4.1 Japan
    • 16.4.11.1 Japan Market Size and Forecast, by Type
    • 16.4.11.2 Japan Market Size and Forecast, by Product
    • 16.4.11.3 Japan Market Size and Forecast, by Services
    • 16.4.11.4 Japan Market Size and Forecast, by Technology
    • 16.4.11.5 Japan Market Size and Forecast, by Application
    • 16.4.11.6 Japan Market Size and Forecast, by End User
    • 16.4.11.7 Japan Market Size and Forecast, by Process
    • 16.4.11.8 Japan Market Size and Forecast, by Mode
    • 16.4.11.9 Japan Market Size and Forecast, by Stage
    • 16.4.11.10 Local Competition Analysis
    • 16.4.11.11 Local Market Analysis
  • 16.4.1 South Korea
    • 16.4.12.1 South Korea Market Size and Forecast, by Type
    • 16.4.12.2 South Korea Market Size and Forecast, by Product
    • 16.4.12.3 South Korea Market Size and Forecast, by Services
    • 16.4.12.4 South Korea Market Size and Forecast, by Technology
    • 16.4.12.5 South Korea Market Size and Forecast, by Application
    • 16.4.12.6 South Korea Market Size and Forecast, by End User
    • 16.4.12.7 South Korea Market Size and Forecast, by Process
    • 16.4.12.8 South Korea Market Size and Forecast, by Mode
    • 16.4.12.9 South Korea Market Size and Forecast, by Stage
    • 16.4.12.10 Local Competition Analysis
    • 16.4.12.11 Local Market Analysis
  • 16.4.1 Australia
    • 16.4.13.1 Australia Market Size and Forecast, by Type
    • 16.4.13.2 Australia Market Size and Forecast, by Product
    • 16.4.13.3 Australia Market Size and Forecast, by Services
    • 16.4.13.4 Australia Market Size and Forecast, by Technology
    • 16.4.13.5 Australia Market Size and Forecast, by Application
    • 16.4.13.6 Australia Market Size and Forecast, by End User
    • 16.4.13.7 Australia Market Size and Forecast, by Process
    • 16.4.13.8 Australia Market Size and Forecast, by Mode
    • 16.4.13.9 Australia Market Size and Forecast, by Stage
    • 16.4.13.10 Local Competition Analysis
    • 16.4.13.11 Local Market Analysis
  • 16.4.1 Singapore
    • 16.4.14.1 Singapore Market Size and Forecast, by Type
    • 16.4.14.2 Singapore Market Size and Forecast, by Product
    • 16.4.14.3 Singapore Market Size and Forecast, by Services
    • 16.4.14.4 Singapore Market Size and Forecast, by Technology
    • 16.4.14.5 Singapore Market Size and Forecast, by Application
    • 16.4.14.6 Singapore Market Size and Forecast, by End User
    • 16.4.14.7 Singapore Market Size and Forecast, by Process
    • 16.4.14.8 Singapore Market Size and Forecast, by Mode
    • 16.4.14.9 Singapore Market Size and Forecast, by Stage
    • 16.4.14.10 Local Competition Analysis
    • 16.4.14.11 Local Market Analysis
  • 16.4.1 Indonesia
    • 16.4.15.1 Indonesia Market Size and Forecast, by Type
    • 16.4.15.2 Indonesia Market Size and Forecast, by Product
    • 16.4.15.3 Indonesia Market Size and Forecast, by Services
    • 16.4.15.4 Indonesia Market Size and Forecast, by Technology
    • 16.4.15.5 Indonesia Market Size and Forecast, by Application
    • 16.4.15.6 Indonesia Market Size and Forecast, by End User
    • 16.4.15.7 Indonesia Market Size and Forecast, by Process
    • 16.4.15.8 Indonesia Market Size and Forecast, by Mode
    • 16.4.15.9 Indonesia Market Size and Forecast, by Stage
    • 16.4.15.10 Local Competition Analysis
    • 16.4.15.11 Local Market Analysis
  • 16.4.1 Taiwan
    • 16.4.16.1 Taiwan Market Size and Forecast, by Type
    • 16.4.16.2 Taiwan Market Size and Forecast, by Product
    • 16.4.16.3 Taiwan Market Size and Forecast, by Services
    • 16.4.16.4 Taiwan Market Size and Forecast, by Technology
    • 16.4.16.5 Taiwan Market Size and Forecast, by Application
    • 16.4.16.6 Taiwan Market Size and Forecast, by End User
    • 16.4.16.7 Taiwan Market Size and Forecast, by Process
    • 16.4.16.8 Taiwan Market Size and Forecast, by Mode
    • 16.4.16.9 Taiwan Market Size and Forecast, by Stage
    • 16.4.16.10 Local Competition Analysis
    • 16.4.16.11 Local Market Analysis
  • 16.4.1 Malaysia
    • 16.4.17.1 Malaysia Market Size and Forecast, by Type
    • 16.4.17.2 Malaysia Market Size and Forecast, by Product
    • 16.4.17.3 Malaysia Market Size and Forecast, by Services
    • 16.4.17.4 Malaysia Market Size and Forecast, by Technology
    • 16.4.17.5 Malaysia Market Size and Forecast, by Application
    • 16.4.17.6 Malaysia Market Size and Forecast, by End User
    • 16.4.17.7 Malaysia Market Size and Forecast, by Process
    • 16.4.17.8 Malaysia Market Size and Forecast, by Mode
    • 16.4.17.9 Malaysia Market Size and Forecast, by Stage
    • 16.4.17.10 Local Competition Analysis
    • 16.4.17.11 Local Market Analysis
  • 16.4.1 Rest of Asia-Pacific
    • 16.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
    • 16.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
    • 16.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
    • 16.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
    • 16.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Application
    • 16.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by End User
    • 16.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Process
    • 16.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Mode
    • 16.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Stage
    • 16.4.18.10 Local Competition Analysis
    • 16.4.18.11 Local Market Analysis
• 16.1 Latin America
  • 16.5.1 Key Market Trends and Opportunities
  • 16.5.2 Latin America Market Size and Forecast, by Type
  • 16.5.3 Latin America Market Size and Forecast, by Product
  • 16.5.4 Latin America Market Size and Forecast, by Services
  • 16.5.5 Latin America Market Size and Forecast, by Technology
  • 16.5.6 Latin America Market Size and Forecast, by Application
  • 16.5.7 Latin America Market Size and Forecast, by End User
  • 16.5.8 Latin America Market Size and Forecast, by Process
  • 16.5.9 Latin America Market Size and Forecast, by Mode
  • 16.5.10 Latin America Market Size and Forecast, by Stage
  • 16.5.11 Latin America Market Size and Forecast, by Country
  • 16.5.12 Brazil
    • 16.5.9.1 Brazil Market Size and Forecast, by Type
    • 16.5.9.2 Brazil Market Size and Forecast, by Product
    • 16.5.9.3 Brazil Market Size and Forecast, by Services
    • 16.5.9.4 Brazil Market Size and Forecast, by Technology
    • 16.5.9.5 Brazil Market Size and Forecast, by Application
    • 16.5.9.6 Brazil Market Size and Forecast, by End User
    • 16.5.9.7 Brazil Market Size and Forecast, by Process
    • 16.5.9.8 Brazil Market Size and Forecast, by Mode
    • 16.5.9.9 Brazil Market Size and Forecast, by Stage
    • 16.5.9.10 Local Competition Analysis
    • 16.5.9.11 Local Market Analysis
  • 16.5.1 Mexico
    • 16.5.10.1 Mexico Market Size and Forecast, by Type
    • 16.5.10.2 Mexico Market Size and Forecast, by Product
    • 16.5.10.3 Mexico Market Size and Forecast, by Services
    • 16.5.10.4 Mexico Market Size and Forecast, by Technology
    • 16.5.10.5 Mexico Market Size and Forecast, by Application
    • 16.5.10.6 Mexico Market Size and Forecast, by End User
    • 16.5.10.7 Mexico Market Size and Forecast, by Process
    • 16.5.10.8 Mexico Market Size and Forecast, by Mode
    • 16.5.10.9 Mexico Market Size and Forecast, by Stage
    • 16.5.10.10 Local Competition Analysis
    • 16.5.10.11 Local Market Analysis
  • 16.5.1 Argentina
    • 16.5.11.1 Argentina Market Size and Forecast, by Type
    • 16.5.11.2 Argentina Market Size and Forecast, by Product
    • 16.5.11.3 Argentina Market Size and Forecast, by Services
    • 16.5.11.4 Argentina Market Size and Forecast, by Technology
    • 16.5.11.5 Argentina Market Size and Forecast, by Application
    • 16.5.11.6 Argentina Market Size and Forecast, by End User
    • 16.5.11.7 Argentina Market Size and Forecast, by Process
    • 16.5.11.8 Argentina Market Size and Forecast, by Mode
    • 16.5.11.9 Argentina Market Size and Forecast, by Stage
    • 16.5.11.10 Local Competition Analysis
    • 16.5.11.11 Local Market Analysis
  • 16.5.1 Rest of Latin America
    • 16.5.12.1 Rest of Latin America Market Size and Forecast, by Type
    • 16.5.12.2 Rest of Latin America Market Size and Forecast, by Product
    • 16.5.12.3 Rest of Latin America Market Size and Forecast, by Services
    • 16.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
    • 16.5.12.5 Rest of Latin America Market Size and Forecast, by Application
    • 16.5.12.6 Rest of Latin America Market Size and Forecast, by End User
    • 16.5.12.7 Rest of Latin America Market Size and Forecast, by Process
    • 16.5.12.8 Rest of Latin America Market Size and Forecast, by Mode
    • 16.5.12.9 Rest of Latin America Market Size and Forecast, by Stage
    • 16.5.12.10 Local Competition Analysis
    • 16.5.12.11 Local Market Analysis
• 16.1 Middle East and Africa
  • 16.6.1 Key Market Trends and Opportunities
  • 16.6.2 Middle East and Africa Market Size and Forecast, by Type
  • 16.6.3 Middle East and Africa Market Size and Forecast, by Product
  • 16.6.4 Middle East and Africa Market Size and Forecast, by Services
  • 16.6.5 Middle East and Africa Market Size and Forecast, by Technology
  • 16.6.6 Middle East and Africa Market Size and Forecast, by Application
  • 16.6.7 Middle East and Africa Market Size and Forecast, by End User
  • 16.6.8 Middle East and Africa Market Size and Forecast, by Process
  • 16.6.9 Middle East and Africa Market Size and Forecast, by Mode
  • 16.6.10 Middle East and Africa Market Size and Forecast, by Stage
  • 16.6.11 Middle East and Africa Market Size and Forecast, by Country
  • 16.6.12 Saudi Arabia
    • 16.6.9.1 Saudi Arabia Market Size and Forecast, by Type
    • 16.6.9.2 Saudi Arabia Market Size and Forecast, by Product
    • 16.6.9.3 Saudi Arabia Market Size and Forecast, by Services
    • 16.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
    • 16.6.9.5 Saudi Arabia Market Size and Forecast, by Application
    • 16.6.9.6 Saudi Arabia Market Size and Forecast, by End User
    • 16.6.9.7 Saudi Arabia Market Size and Forecast, by Process
    • 16.6.9.8 Saudi Arabia Market Size and Forecast, by Mode
    • 16.6.9.9 Saudi Arabia Market Size and Forecast, by Stage
    • 16.6.9.10 Local Competition Analysis
    • 16.6.9.11 Local Market Analysis
  • 16.6.1 UAE
    • 16.6.10.1 UAE Market Size and Forecast, by Type
    • 16.6.10.2 UAE Market Size and Forecast, by Product
    • 16.6.10.3 UAE Market Size and Forecast, by Services
    • 16.6.10.4 UAE Market Size and Forecast, by Technology
    • 16.6.10.5 UAE Market Size and Forecast, by Application
    • 16.6.10.6 UAE Market Size and Forecast, by End User
    • 16.6.10.7 UAE Market Size and Forecast, by Process
    • 16.6.10.8 UAE Market Size and Forecast, by Mode
    • 16.6.10.9 UAE Market Size and Forecast, by Stage
    • 16.6.10.10 Local Competition Analysis
    • 16.6.10.11 Local Market Analysis
  • 16.6.1 South Africa
    • 16.6.11.1 South Africa Market Size and Forecast, by Type
    • 16.6.11.2 South Africa Market Size and Forecast, by Product
    • 16.6.11.3 South Africa Market Size and Forecast, by Services
    • 16.6.11.4 South Africa Market Size and Forecast, by Technology
    • 16.6.11.5 South Africa Market Size and Forecast, by Application
    • 16.6.11.6 South Africa Market Size and Forecast, by End User
    • 16.6.11.7 South Africa Market Size and Forecast, by Process
    • 16.6.11.8 South Africa Market Size and Forecast, by Mode
    • 16.6.11.9 South Africa Market Size and Forecast, by Stage
    • 16.6.11.10 Local Competition Analysis
    • 16.6.11.11 Local Market Analysis
  • 16.6.1 Rest of MEA
    • 16.6.12.1 Rest of MEA Market Size and Forecast, by Type
    • 16.6.12.2 Rest of MEA Market Size and Forecast, by Product
    • 16.6.12.3 Rest of MEA Market Size and Forecast, by Services
    • 16.6.12.4 Rest of MEA Market Size and Forecast, by Technology
    • 16.6.12.5 Rest of MEA Market Size and Forecast, by Application
    • 16.6.12.6 Rest of MEA Market Size and Forecast, by End User
    • 16.6.12.7 Rest of MEA Market Size and Forecast, by Process
    • 16.6.12.8 Rest of MEA Market Size and Forecast, by Mode
    • 16.6.12.9 Rest of MEA Market Size and Forecast, by Stage
    • 16.6.12.10 Local Competition Analysis
    • 16.6.12.11 Local Market Analysis

17: Competitive Landscape

• 17.1 Overview
• 17.2 Market Share Analysis
• 17.3 Key Player Positioning
• 17.4 Competitive Leadership Mapping
  • 17.4.1 Star Players
  • 17.4.2 Innovators
  • 17.4.3 Emerging Players
• 17.5 Vendor Benchmarking
• 17.6 Developmental Strategy Benchmarking
  • 17.6.1 New Product Developments
  • 17.6.2 Product Launches
  • 17.6.3 Business Expansions
  • 17.6.4 Partnerships, Joint Ventures, and Collaborations
  • 17.6.5 Mergers and Acquisitions

18: Company Profiles

• 18.1 Bluebird Bio
  • 18.1.1 Company Overview
  • 18.1.2 Company Snapshot
  • 18.1.3 Business Segments
  • 18.1.4 Business Performance
  • 18.1.5 Product Offerings
  • 18.1.6 Key Developmental Strategies
  • 18.1.7 SWOT Analysis
• 18.2 Sangamo Therapeutics
  • 18.2.1 Company Overview
  • 18.2.2 Company Snapshot
  • 18.2.3 Business Segments
  • 18.2.4 Business Performance
  • 18.2.5 Product Offerings
  • 18.2.6 Key Developmental Strategies
  • 18.2.7 SWOT Analysis
• 18.3 Adaptimmune Therapeutics
  • 18.3.1 Company Overview
  • 18.3.2 Company Snapshot
  • 18.3.3 Business Segments
  • 18.3.4 Business Performance
  • 18.3.5 Product Offerings
  • 18.3.6 Key Developmental Strategies
  • 18.3.7 SWOT Analysis
• 18.4 Atara Biotherapeutics
  • 18.4.1 Company Overview
  • 18.4.2 Company Snapshot
  • 18.4.3 Business Segments
  • 18.4.4 Business Performance
  • 18.4.5 Product Offerings
  • 18.4.6 Key Developmental Strategies
  • 18.4.7 SWOT Analysis
• 18.5 Cellectis
  • 18.5.1 Company Overview
  • 18.5.2 Company Snapshot
  • 18.5.3 Business Segments
  • 18.5.4 Business Performance
  • 18.5.5 Product Offerings
  • 18.5.6 Key Developmental Strategies
  • 18.5.7 SWOT Analysis
• 18.6 Fate Therapeutics
  • 18.6.1 Company Overview
  • 18.6.2 Company Snapshot
  • 18.6.3 Business Segments
  • 18.6.4 Business Performance
  • 18.6.5 Product Offerings
  • 18.6.6 Key Developmental Strategies
  • 18.6.7 SWOT Analysis
• 18.7 Gamida Cell
  • 18.7.1 Company Overview
  • 18.7.2 Company Snapshot
  • 18.7.3 Business Segments
  • 18.7.4 Business Performance
  • 18.7.5 Product Offerings
  • 18.7.6 Key Developmental Strategies
  • 18.7.7 SWOT Analysis
• 18.8 Kiadis Pharma
  • 18.8.1 Company Overview
  • 18.8.2 Company Snapshot
  • 18.8.3 Business Segments
  • 18.8.4 Business Performance
  • 18.8.5 Product Offerings
  • 18.8.6 Key Developmental Strategies
  • 18.8.7 SWOT Analysis
• 18.9 Mesoblast
  • 18.9.1 Company Overview
  • 18.9.2 Company Snapshot
  • 18.9.3 Business Segments
  • 18.9.4 Business Performance
  • 18.9.5 Product Offerings
  • 18.9.6 Key Developmental Strategies
  • 18.9.7 SWOT Analysis
• 18.10 Orchard Therapeutics
  • 18.10.1 Company Overview
  • 18.10.2 Company Snapshot
  • 18.10.3 Business Segments
  • 18.10.4 Business Performance
  • 18.10.5 Product Offerings
  • 18.10.6 Key Developmental Strategies
  • 18.10.7 SWOT Analysis
• 18.11 Poseida Therapeutics
  • 18.11.1 Company Overview
  • 18.11.2 Company Snapshot
  • 18.11.3 Business Segments
  • 18.11.4 Business Performance
  • 18.11.5 Product Offerings
  • 18.11.6 Key Developmental Strategies
  • 18.11.7 SWOT Analysis
• 18.12 Precision BioSciences
  • 18.12.1 Company Overview
  • 18.12.2 Company Snapshot
  • 18.12.3 Business Segments
  • 18.12.4 Business Performance
  • 18.12.5 Product Offerings
  • 18.12.6 Key Developmental Strategies
  • 18.12.7 SWOT Analysis
• 18.13 Regenxbio
  • 18.13.1 Company Overview
  • 18.13.2 Company Snapshot
  • 18.13.3 Business Segments
  • 18.13.4 Business Performance
  • 18.13.5 Product Offerings
  • 18.13.6 Key Developmental Strategies
  • 18.13.7 SWOT Analysis
• 18.14 Rubius Therapeutics
  • 18.14.1 Company Overview
  • 18.14.2 Company Snapshot
  • 18.14.3 Business Segments
  • 18.14.4 Business Performance
  • 18.14.5 Product Offerings
  • 18.14.6 Key Developmental Strategies
  • 18.14.7 SWOT Analysis
• 18.15 Sorrento Therapeutics
  • 18.15.1 Company Overview
  • 18.15.2 Company Snapshot
  • 18.15.3 Business Segments
  • 18.15.4 Business Performance
  • 18.15.5 Product Offerings
  • 18.15.6 Key Developmental Strategies
  • 18.15.7 SWOT Analysis
• 18.16 TCR2 Therapeutics
  • 18.16.1 Company Overview
  • 18.16.2 Company Snapshot
  • 18.16.3 Business Segments
  • 18.16.4 Business Performance
  • 18.16.5 Product Offerings
  • 18.16.6 Key Developmental Strategies
  • 18.16.7 SWOT Analysis
• 18.17 Unum Therapeutics
  • 18.17.1 Company Overview
  • 18.17.2 Company Snapshot
  • 18.17.3 Business Segments
  • 18.17.4 Business Performance
  • 18.17.5 Product Offerings
  • 18.17.6 Key Developmental Strategies
  • 18.17.7 SWOT Analysis
• 18.18 Vericel
  • 18.18.1 Company Overview
  • 18.18.2 Company Snapshot
  • 18.18.3 Business Segments
  • 18.18.4 Business Performance
  • 18.18.5 Product Offerings
  • 18.18.6 Key Developmental Strategies
  • 18.18.7 SWOT Analysis
• 18.19 Ziopharm Oncology
  • 18.19.1 Company Overview
  • 18.19.2 Company Snapshot
  • 18.19.3 Business Segments
  • 18.19.4 Business Performance
  • 18.19.5 Product Offerings
  • 18.19.6 Key Developmental Strategies
  • 18.19.7 SWOT Analysis
• 18.20 Allogene Therapeutics
  • 18.20.1 Company Overview
  • 18.20.2 Company Snapshot
  • 18.20.3 Business Segments
  • 18.20.4 Business Performance
  • 18.20.5 Product Offerings
  • 18.20.6 Key Developmental Strategies
  • 18.20.7 SWOT Analysis